Home › PTC Jumps Most Since 2014 as U.K. Regulator Recommends DMD Drug
 

Keywords :   


PTC Jumps Most Since 2014 as U.K. Regulator Recommends DMD Drug

2016-04-16 18:41:20| Biotech - Topix.net

PTC Therapeutics Inc. soared the most since May 2014 after the U.K.'s health-cost regulator recommended its drug for a deadly muscle disease. The U.K.'s National Institute for Health and Care Excellence, known as NICE, recommended PTC's drug Translarna for some patients with Duchenne muscular dystrophy in England, according to a statement Friday.

Tags: drug recommends regulator jumps

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06Potential Tropical Cyclone One Graphics
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Potential Tropical Cyclone One Forecast Advisory Number 5
18.06Nvidia becomes world's most valuable company
18.06CEO Spotlight: Catching Up with Ron Mittelstaedt of Waste Connections
18.06KDV Label names Gary Morrison SVP sales and marketing
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 4A
More »